American Health Research Institute

Institution (Facility)

Homepage ROR

Also Known As

American Health Research Institute · Acronym: AHRI

Publications

450

Citations

Authors

Concepts

About

American Health Research Institute is a facility institution in Birmingham, United States known for medicine, anesthesiology, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	4	227
2	Public Health	1	2	68
3	Epidemiology	1	2	68
4	Health Policy	1	2	68
5	Pharmacology	1	1	57

American Health Research Institute

Publications

450

Citations

Page 1

	Year	Citations
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson, CHEST Journal Pulmonary CareAdvanced Lung DiseasePulmonary MedicineMedicinePulmonary Disease	2016	102
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients Claus Vogelmeier, C. Verkindre, D. Cheung, Pulmonary Pharmacology & Therapeutics Molecular PharmacologyMedicinePulmonary PharmacologyNeuropharmacologyCopd Patients	2010	57
Pediatric Thyroid Carcinoma Incidence and Temporal Trends in the USA (1973–2007): Race or Shifting Diagnostic Paradigm? Laurens Holmes, Jobayer Hossain, Franklin Opara ISRN Oncology	2012	55
Racial/Ethnic Variability in Hypertension Prevalence and Risk Factors in National Health Interview Survey Laurens Holmes, Jobayer Hossain, Doriel Ward, ISRN Hypertension EthnicityRacial/ethnic VariabilityHypertensionRacial/ethnic DisparitiesHealth Disparities	2012	34
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease Colin Reisner, Leonardo M. Fabbri, Edward Kerwin, Respiratory Research	2017	24
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study Vivek Khanna, Gregory Feldman, Selwyn Spangenthal, International Journal of COPD	2016	24
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD Leonardo M. Fabbri, Edward Kerwin, Selwyn Spangenthal, Respiratory Research	2016	18
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease Faisal Fakih, Selwyn Spangenthal, Barry Sigal, Respiratory Medicine	2018	15
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD Courtney Crim, Mark H. Gotfried, Selwyn Spangenthal, BMC Pulmonary Medicine	2020	14

Page 1